Price Target

Emerson Electric Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo

JMP Securities initiates coverage on Summit Therapeutics, citing promising data for ivonescimab in NSCLC and setting a $32 price target amid strong trial results.

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.

Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

Lululemon's China Comeback, Analyst Sees 60% Q3 Growth

Lorraine Hutchinson, BofA Securities analyst, reiterated a Buy rating for LULU with a $355 price target. Data shows strong sales in China, reinforcing confidence in LULU's growth potential. China plays a key role in LULU's long-term plan for international revenue growth.

Apple's Services And Silicon Strategy To Fuel Margins, Justify High Valuation: Analyst

BofA Securities analyst maintains Buy rating on Apple Inc with $256 price target. Strong iPhone upgrade cycle, higher margins and AI features justify high valuation.

NXP Semiconductors Earnings Are Imminent; These Major Analysts Revise Forecasts Ahead Of Earnings Call

This Peloton Interactive Analyst Gives A Double Upgrade, Raises Forecast By More Than 100%

Peloton smashed sales estimates in Q1. One analyst says the company has the potential for $300-million EBITDA this year.

Chevron Posts Q3 Beat As 'Uncertainty Around Hess Deal Remains,' Analysts Say

Chevron's Q3 earnings beat expectations, driven by record production in Permian. Analysts maintain positive outlook on acquisition potential and cost reductions.

Palantir Technologies Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Top Analysts

These Analysts Revise Their Forecasts On Generac After Q4 Results

Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease

Merck's Q3 revenue rises, led by Keytruda's strong 17% YoY growth. Gardasil demand challenges in China impact sales, with Winrevair showing promising performance.

Service Corp International Analysts Boost Their Forecasts After Upbeat Earnings

Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges

Shell's Q3 earnings beat expectations with $71.09 billion in revenue and $3.5 billion in buybacks, supported by broad-based performance. RBC analyst reiterated the Outperform rating on Shell.

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology.

ConocoPhillips-Marathon Synergy Will Boost Free Cash Flow And Stock Buyback: Analyst

Analysts comment on ConocoPhillips' mixed Q3 results, with EPS beating estimates but revenue missing. Company raises dividend and production outlook.

Amazon Analysts See Growth Ahead With AWS In 'Early Innings Of A Big AI Cycle,' Advertising Segment Fast-Growing 'Hidden Asset'

Amazon analysts raise price targets for the stock and center in on AWS growth and the AI opportunity with advertising called a future catalyst.

Uber's Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships

Uber's Q3 results beat analyst expectations. JMP Securities sees opportunity for growth, raises target to $95. KeyBanc cautious on slower mobility growth.

Intel Struggles With Market Share, Profitability: Q3 Analyst Insights

Intel on Thursday reported Q3 results. What do analysts think?

Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'

Argenx SE ADR shares jumped after impressive earnings. Analysts raised price targets and noted strong pipeline and global expansion.

Apple Q4 Results 'Better-Than-Feared': Analysts Highlight iPhone 16 Demand, Apple Intelligence Opportunity After 'Rock Solid Quarter'

Apple beat estimates in the fourth quarter, but the company's guidance outlook has some analysts concerned.

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Top 3 Energy Stocks That Are Preparing To Pump In November

Top 2 Utilities Stocks That May Crash This Quarter

Starbucks Faces Sales Slump But Analysts See Silver Lining With New CEO's Efficiency Strategy

Starbucks Q4 earnings miss estimates, prompting analysts to highlight limited near-term visibility but confidence in long-term margin growth.

What's Going On With Roku Stock Thursday?

Roku Inc (NASDAQ:ROKU) shares are trading lower on Thursday following the company's third-quarter financial results.

Coinbase Analysts Remain Polarized Following Poor Earnings, Note Possible Future Political Tailwinds

Coinbase Global sunk deep into the red on Thursday following poor third-quarter results. It remains polarizing among analysts.

L3Harris And Palantir Collaboration Key To Future Growth, BofA Upgrades Stock

L3Harris upgraded to Buy from Neutral, price target raised to $300 from $240. Recent results and strategic partnerships show strong growth potential for this missile and munitions industry leader.

Biogen Analysts Slash Their Forecasts After Q3 Results

Meta Platforms To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday